Effects of Carboplatin and Isotretinoin on Participants With High Risk Medulloblastoma
Clinical Trial
Offered by: 波色单双
Locations: Delaware Valley and Pensacola in Florida
Trial Name
Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients.
What is the trial about?
Compare effects of the chemotherapy drugs carboplatin and isotretinoin on participants with high risk medulloblastoma and to find out if one or both are better than standard therapy alone.
Who can participate?
> 3 and < 22 yrs of age.
What is involved?
Length of study is 9-15 months. Standard cancer care including additional hearing and blood tests.
Is a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.
![Two researchers in a lab wearing coats and gloves, one looks into a microscope. Two researchers in a lab wearing coats and gloves, one looks into a microscope.](/content/experience-fragments/nemours/us/en/site/clinical-trial/clinical-trails/_jcr_content/root/two_panel_block_righ/col2/image.coreimg.jpeg/1686927063568/block-research-lab-microscope.jpeg)